US36315X1019 - ADR
Galapagos NV enters strategic collaboration with Thermo Fisher for decentralized manufacturing of CAR-T product in San Francisco area, effective January...
Galapagos (GLPG) has entered into a strategic collaboration deal with BridGene Biosciences, with Galapagos receiving the exclusive right to commercialize any resulting products.
/PRNewswire/ -- BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditional "hard-to-drug" targets, announced today a...
Galapagos (GLPG) Tuesday said it entered into a deal to sell its Jyseleca business to Italian pharma company Alfasigma. Per the terms, Galapagos will receive a €50 million payment upfront..
GLPG stock results show that Galapagos beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galapagos (NASDAQ:GLPG) just reported results for the third quarter of 2023.Gal...
Galapagos press release (GLPG): Q1 GAAP EPS of €0.40.Revenue of €178.9M (+31.3% Y/Y).Current financial investments and cash and cash equivalents totaled €3,990.1 million on 31 March...
Galapagos (GLPG) notifies the departure of Bart Filius, President, Chief Operating Officer and Chief Financial Officer.Bart Filius will leave the company as per 30 June 2023.A search...
Galapagos (GLPG) stock fell ~8% on Thursday after filgotinib failed to meet the main goals as induction therapy in a phase 3 trial in patients with moderate to severe Crohn's...
Galapagos (GLPG) announced Dr. Walid Abi-Saab has decided to retire from the company as Chief Medical Officer and member of the executive committee, effective 31 December 2022.He will...
Schrödinger (SDGR) and Ventyx Biosciences (VTYX) rallied Tuesday after Takeda (TAK) agreed to pay $4B upfront to acquire a company developing a TYK2 inhibitor. Read full story here.